U.S. Customs and Border Protection unlawfully let Apple Inc. reactivate a blood-oxygen tracking feature on Apple Watches that infringes patents for the technology, Masimo Corp. said in a federal lawsuit. CBP exceeded its authority in an Aug. 1 internal advice ruling that overturned its own January decision without notice or input from Masimo, the medical-device maker said in a complaint filed in the U.S. District Court for the District of Columbia.
Read the article: Bloomberg